US EditionPublished • loading... • Updated
Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation
Investors may seek recovery after Alvotech's stock fell 34% following FDA rejection of its biologics license application, Rosen Law Firm said.
- The Rosen Law Firm in New York opened an investigation on Dec. 13, 2025, targeting Alvotech shareholders over alleged disclosure issues and provided its New York office contact details.
- The FDA's complete response letter noted deficiencies after a pre-license inspection of Alvotech's Reykjavik facility, and markets reacted sharply with shares falling 34% on November 3, 2025, and nearly 4% on November 4, 2025.
- Firm records show significant prior settlements; The Rosen Law Firm, P.A. secured over $438 million in 2019 and achieved the largest-ever securities settlement against a Chinese company.
- The firm is preparing a class action and seeks recovery of losses, urging investors to contact The Rosen Law Firm via online form or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com.
- The Rosen Law Firm, in a recent release, opened an investigation into Alvotech shareholders, with Laurence Rosen, founding partner, recognized by ISS Securities Class Action Services.
Insights by Ground AI
55 Articles
55 Articles
Coverage Details
Total News Sources55
Leaning Left5Leaning Right3Center20Last UpdatedBias Distribution71% Center
Bias Distribution
- 71% of the sources are Center
71% Center
L 18%
C 71%
11%
Factuality
To view factuality data please Upgrade to Premium
